drugset / Trial / NCT04492956
Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)
Phase 2
Completed
68 enrolled
Emalex Biosciences Inc.
Premier Research · collabUniversity of California, Riverside · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase 2 exploratory study in adult subjects with childhood onset fluency disorder.
Timeline
- Start
- 2020-10-02
- Primary completion
- 2022-03-07
- Completion
- 2022-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ecopipam | Small molecule | 2 mg/kg | Oral |